Contact
searchSearch
HMP Global
Videos

Discover Shockwave C2 Aero

05/06/2026

Introducing Shockwave C2 Aero, the latest Aero-volution in coronary calcium modification. Shockwave C2 Aero leverages our proven mechanism of action (MOA), delivering the same consistent circumferential ultrasonic pressure wave output to crack calcium safely and effectively. 

Watch this video to see some of the exciting features of this new design, which offers improved deliverability, a more compact rewrap, improved crossability, and more efficient treatment. https://shockwavemedical.com/products...

Available in the U.S. Shockwave IVL Important Safety Information: https://shockwavemedical.com/isi/


Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

IVUS+OCT
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
05/08/2026
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging  - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO-- Conavi Medical Corp.,...
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging  - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO-- Conavi Medical Corp.,...
- First co-registered and...
05/08/2026
Cath Lab Digest
Device Longevity
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
05/05/2026
The COMMENCE trial provides prospective, 10-year data demonstrating the durability of Edwards’ RESILIA tissue and its role in lifetime management for patients with aortic stenosis.
The COMMENCE trial provides prospective, 10-year data demonstrating the durability of Edwards’ RESILIA tissue and its role in lifetime management for patients with aortic stenosis.
The COMMENCE trial provides...
05/05/2026
Cath Lab Digest
Stroke
Newly Published Study Shows Sensome Clot-Sensing Guidewire Accurately Reveals True Clot Make-Up in Fully Occluded Brain Vessels for First Time
05/05/2026
By integrating the world’s smallest electrical impedance sensor with predictive algorithms into a standard 0.014” guidewire, the Clotild clot-sensing guidewire is designed to provide physicians with real-time, in situ biological intelligence...
By integrating the world’s smallest electrical impedance sensor with predictive algorithms into a standard 0.014” guidewire, the Clotild clot-sensing guidewire is designed to provide physicians with real-time, in situ biological intelligence...
By integrating the world’s...
05/05/2026
Cath Lab Digest
Non-Obstructive HCM
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Non-Obstructive Hypertrophic Cardiomyopathy
05/05/2026
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. --...
05/05/2026
Cath Lab Digest
Mechanical Circulatory Support
Promising Data from US Pilot Study Shows Planned Impella 5.5 Use is Safe and Feasible in Non-Shock, High-Risk Cardiac Surgery Patients
05/05/2026
Chicago, IL – Johnson & Johnson announced results from a novel U.S. pilot single-arm trial that evaluated the safety and feasibility of planned Impella 5.5™ support in adult patients undergoing cardiac surgery in the setting of...
Chicago, IL – Johnson & Johnson announced results from a novel U.S. pilot single-arm trial that evaluated the safety and feasibility of planned Impella 5.5™ support in adult patients undergoing cardiac surgery in the setting of...
Chicago, IL – Johnson &...
05/05/2026
Cath Lab Digest
Drug-Eluting Balloons
Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan 
04/30/2026
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical...
04/30/2026
Cath Lab Digest
J. Dawn Abbott, MD, MSCAI
society news
SCAI Announces J. Dawn Abbott, MD, MSCAI, President for 2026–27
04/30/2026
Dr. Abbott is a nationally recognized leader in interventional cardiology, serving as Professor of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at Brown University Health Cardiovascular...
Dr. Abbott is a nationally recognized leader in interventional cardiology, serving as Professor of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at Brown University Health Cardiovascular...
Dr. Abbott is a nationally...
04/30/2026
Cath Lab Digest
Below-Ankle Intervention
Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle
04/29/2026
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy...
04/29/2026
Vascular Disease Management
Optical Coherence Tomography
Abbott Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 AI-Powered Coronary Imaging Platform
04/28/2026
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery   The integrated imaging...
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery   The integrated imaging...
Ultreon 3.0 is the first...
04/28/2026
Cath Lab Digest
CoraFlex and CoraForce microcatheters (Reflow Medical)
Microcatheters
Reflow Medical Announces U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters
04/24/2026
Designed for complex coronary interventions, the Cora Torqueable Microcatheters introduce enhancements focused on spinning freedom and torque transmission, supporting controlled navigation and lesion crossing in challenging anatomies.
Designed for complex coronary interventions, the Cora Torqueable Microcatheters introduce enhancements focused on spinning freedom and torque transmission, supporting controlled navigation and lesion crossing in challenging anatomies.
Designed for complex coronary...
04/24/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use